chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthritis, Back pain, C-reactive protein, C-reactive protein increased, Erythema nodosum
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Investigation, Myalgia
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain, Pain, Red blood cell sedimentation rate, Red blood cell sedimentation rate increased, SARS-CoV-2 test
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Arthritis, Back pain, C-reactive protein increased, Condition aggravated
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Crying, Dermatitis, Erythema nodosum, Fatigue, Gait disturbance
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Heart rate increased, Hypersensitivity, Illness, Immunology test normal
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Influenza like illness, Insomnia, Joint fluid drainage, Joint swelling, Moaning
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mobility decreased, Myalgia, Neck pain, Pain, Pain in extremity
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate increased, Respiratory tract infection, Urticaria, Vaccination complication
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, Gait disturbance, Joint swelling, Lymphocyte count increased, Neutrophil count increased
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Red blood cell sedimentation rate increased, White blood cell count increased
Clinical narrative: neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Abdominal pain, Blood test, Dyspepsia, Eating disorder
Clinical narrative: discomfort pain at the injection site; can't eat; Nerve pain; arm pain; Abdominal pain; feelings of fullness; Food intolerance; Heartburn; Indigestion; Pancreatitis/my auto immune flares as pancreatitis; This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 14Apr2021 (Batch/Lot Number: ER8731) at the age of 44 years, as single dose for covid-19 immunisation.   Medical history included systemic lupus erythematosus from 1994 and ongoing, hypothyroidism from an unknown date and unknown if ongoing, Addison's disease from an unknown date and unknown if ongoing , autoimmune pancreatitis from 2015 and ongoing.  The patient's concomitant medications were not reported. The patient experienced pancreatitis/my auto immune flares as pancreatitis on 24Apr2021 after 10 days from vaccination. On an unspecified date the patient experienced discomfort pain at the injection site, can't eat, nerve pain, arm pain, abdominal pain, feelings of fullness, food intolerance, heartburn, indigestion.  The patient didn't think her immune response will be as strong. She has lupus, her auto immune flares as pancreatitis. This is one of the most significant flares that she has experienced. The flare is very significant and she is suffering. This is a direct result from the vaccine. Even though she has lupus she is in exceptional health. Her physicians consulted came to the consensus that it getting the vaccine benefit outweighs the risk and chose the pfizer covid vaccine. They knew she may experience a flare, wasn't something uncommon, there was knowledge a flare may happen but nothing so intense. She can't eat. She can only have water and medication. She is going to see what blood results are in.  The patient underwent lab tests and procedures which included blood test: unknown results on unknown date. The outcome of the events was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Food intolerance, Neuralgia, Pain in extremity, Pancreatitis, Vaccination site pain
Clinical narrative: discomfort pain at the injection site; can't eat; Nerve pain; arm pain; Abdominal pain; feelings of fullness; Food intolerance; Heartburn; Indigestion; Pancreatitis/my auto immune flares as pancreatitis; This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 14Apr2021 (Batch/Lot Number: ER8731) at the age of 44 years, as single dose for covid-19 immunisation.   Medical history included systemic lupus erythematosus from 1994 and ongoing, hypothyroidism from an unknown date and unknown if ongoing, Addison's disease from an unknown date and unknown if ongoing , autoimmune pancreatitis from 2015 and ongoing.  The patient's concomitant medications were not reported. The patient experienced pancreatitis/my auto immune flares as pancreatitis on 24Apr2021 after 10 days from vaccination. On an unspecified date the patient experienced discomfort pain at the injection site, can't eat, nerve pain, arm pain, abdominal pain, feelings of fullness, food intolerance, heartburn, indigestion.  The patient didn't think her immune response will be as strong. She has lupus, her auto immune flares as pancreatitis. This is one of the most significant flares that she has experienced. The flare is very significant and she is suffering. This is a direct result from the vaccine. Even though she has lupus she is in exceptional health. Her physicians consulted came to the consensus that it getting the vaccine benefit outweighs the risk and chose the pfizer covid vaccine. They knew she may experience a flare, wasn't something uncommon, there was knowledge a flare may happen but nothing so intense. She can't eat. She can only have water and medication. She is going to see what blood results are in.  The patient underwent lab tests and procedures which included blood test: unknown results on unknown date. The outcome of the events was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Amylase abnormal, Anaemia, Blood immunoglobulin G, Blood thyroid stimulating hormone increased
Clinical narrative: discomfort pain at the injection site; can't eat; Nerve pain; arm pain; Abdominal pain; feelings of fullness; Food intolerance; Heartburn; Indigestion; Pancreatitis/my auto immune flares as pancreatitis; This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 14Apr2021 (Batch/Lot Number: ER8731) at the age of 44 years, as single dose for covid-19 immunisation.   Medical history included systemic lupus erythematosus from 1994 and ongoing, hypothyroidism from an unknown date and unknown if ongoing, Addison's disease from an unknown date and unknown if ongoing , autoimmune pancreatitis from 2015 and ongoing.  The patient's concomitant medications were not reported. The patient experienced pancreatitis/my auto immune flares as pancreatitis on 24Apr2021 after 10 days from vaccination. On an unspecified date the patient experienced discomfort pain at the injection site, can't eat, nerve pain, arm pain, abdominal pain, feelings of fullness, food intolerance, heartburn, indigestion.  The patient didn't think her immune response will be as strong. She has lupus, her auto immune flares as pancreatitis. This is one of the most significant flares that she has experienced. The flare is very significant and she is suffering. This is a direct result from the vaccine. Even though she has lupus she is in exceptional health. Her physicians consulted came to the consensus that it getting the vaccine benefit outweighs the risk and chose the pfizer covid vaccine. They knew she may experience a flare, wasn't something uncommon, there was knowledge a flare may happen but nothing so intense. She can't eat. She can only have water and medication. She is going to see what blood results are in.  The patient underwent lab tests and procedures which included blood test: unknown results on unknown date. The outcome of the events was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Differential white blood cell count, Double stranded DNA antibody, Fatigue, Full blood count abnormal, Glycosylated haemoglobin
Clinical narrative: discomfort pain at the injection site; can't eat; Nerve pain; arm pain; Abdominal pain; feelings of fullness; Food intolerance; Heartburn; Indigestion; Pancreatitis/my auto immune flares as pancreatitis; This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 14Apr2021 (Batch/Lot Number: ER8731) at the age of 44 years, as single dose for covid-19 immunisation.   Medical history included systemic lupus erythematosus from 1994 and ongoing, hypothyroidism from an unknown date and unknown if ongoing, Addison's disease from an unknown date and unknown if ongoing , autoimmune pancreatitis from 2015 and ongoing.  The patient's concomitant medications were not reported. The patient experienced pancreatitis/my auto immune flares as pancreatitis on 24Apr2021 after 10 days from vaccination. On an unspecified date the patient experienced discomfort pain at the injection site, can't eat, nerve pain, arm pain, abdominal pain, feelings of fullness, food intolerance, heartburn, indigestion.  The patient didn't think her immune response will be as strong. She has lupus, her auto immune flares as pancreatitis. This is one of the most significant flares that she has experienced. The flare is very significant and she is suffering. This is a direct result from the vaccine. Even though she has lupus she is in exceptional health. Her physicians consulted came to the consensus that it getting the vaccine benefit outweighs the risk and chose the pfizer covid vaccine. They knew she may experience a flare, wasn't something uncommon, there was knowledge a flare may happen but nothing so intense. She can't eat. She can only have water and medication. She is going to see what blood results are in.  The patient underwent lab tests and procedures which included blood test: unknown results on unknown date. The outcome of the events was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypothyroidism, Injection site pain, Lipase abnormal, Mean cell haemoglobin concentration decreased, Metabolic function test
Clinical narrative: discomfort pain at the injection site; can't eat; Nerve pain; arm pain; Abdominal pain; feelings of fullness; Food intolerance; Heartburn; Indigestion; Pancreatitis/my auto immune flares as pancreatitis; This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 14Apr2021 (Batch/Lot Number: ER8731) at the age of 44 years, as single dose for covid-19 immunisation.   Medical history included systemic lupus erythematosus from 1994 and ongoing, hypothyroidism from an unknown date and unknown if ongoing, Addison's disease from an unknown date and unknown if ongoing , autoimmune pancreatitis from 2015 and ongoing.  The patient's concomitant medications were not reported. The patient experienced pancreatitis/my auto immune flares as pancreatitis on 24Apr2021 after 10 days from vaccination. On an unspecified date the patient experienced discomfort pain at the injection site, can't eat, nerve pain, arm pain, abdominal pain, feelings of fullness, food intolerance, heartburn, indigestion.  The patient didn't think her immune response will be as strong. She has lupus, her auto immune flares as pancreatitis. This is one of the most significant flares that she has experienced. The flare is very significant and she is suffering. This is a direct result from the vaccine. Even though she has lupus she is in exceptional health. Her physicians consulted came to the consensus that it getting the vaccine benefit outweighs the risk and chose the pfizer covid vaccine. They knew she may experience a flare, wasn't something uncommon, there was knowledge a flare may happen but nothing so intense. She can't eat. She can only have water and medication. She is going to see what blood results are in.  The patient underwent lab tests and procedures which included blood test: unknown results on unknown date. The outcome of the events was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pancreatitis, SARS-CoV-2 antibody test
Clinical narrative: discomfort pain at the injection site; can't eat; Nerve pain; arm pain; Abdominal pain; feelings of fullness; Food intolerance; Heartburn; Indigestion; Pancreatitis/my auto immune flares as pancreatitis; This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 14Apr2021 (Batch/Lot Number: ER8731) at the age of 44 years, as single dose for covid-19 immunisation.   Medical history included systemic lupus erythematosus from 1994 and ongoing, hypothyroidism from an unknown date and unknown if ongoing, Addison's disease from an unknown date and unknown if ongoing , autoimmune pancreatitis from 2015 and ongoing.  The patient's concomitant medications were not reported. The patient experienced pancreatitis/my auto immune flares as pancreatitis on 24Apr2021 after 10 days from vaccination. On an unspecified date the patient experienced discomfort pain at the injection site, can't eat, nerve pain, arm pain, abdominal pain, feelings of fullness, food intolerance, heartburn, indigestion.  The patient didn't think her immune response will be as strong. She has lupus, her auto immune flares as pancreatitis. This is one of the most significant flares that she has experienced. The flare is very significant and she is suffering. This is a direct result from the vaccine. Even though she has lupus she is in exceptional health. Her physicians consulted came to the consensus that it getting the vaccine benefit outweighs the risk and chose the pfizer covid vaccine. They knew she may experience a flare, wasn't something uncommon, there was knowledge a flare may happen but nothing so intense. She can't eat. She can only have water and medication. She is going to see what blood results are in.  The patient underwent lab tests and procedures which included blood test: unknown results on unknown date. The outcome of the events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Deafness unilateral, Tinnitus
Clinical narrative: Hearing loss in right ear; the ringing was much louder now than ever before; the ringing was much louder now than ever before; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on an unspecified date in 2021 (Lot Number: EX 6200), as single dose, for COVID-19 immunisation. Medical history included ongoing tinnitus (before the 2 vaccinations). Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) for COVID-19 immunisation on 17Feb2021 (lot# EL9262, at 12:00 PM, in left arm). The patient experienced hearing loss in right ear (medically significant) in 2021 with outcome of not recovered, the ringing was much louder now than ever before (non-serious) in 2021 with outcome of not recovered. The patient reported to have mild to medium ringing in ears before the injections. She reported the ringing was much louder now than ever before. The tones were different in each ear. It was almost unbearable at times. She also lost some hearing in right ear, left ear was fine. Since the vaccination the patient was not tested for COVID-19.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Deafness unilateral, Magnetic resonance imaging, Positron emission tomogram
Clinical narrative: Complete unilateral hearing loss right ear; This is a spontaneous report from a contactable nurse. An 80-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), in Feb2021 (Lot not reported) as 1 st dose, single then on 18Mar2021 (Lot not reported) as 2 nd dose, single; both intramuscular (at the age of 80-years-old) for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19 and since vaccination, patient was not tested for COVID-19. Medical history included neoplasm malignant. The patient's concomitant medications were not reported. The reported adverse event was complete unilateral hearing loss right ear on 27Mar2021. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Treatment received were PET-scan (in 2021), MRI (in 2021), hearing test (in 2021), antibiotics and prednisone. The outcome of the event was recovered with sequel in 2021.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available a causal relationship between event unilateral hearing loss right ear and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Tested positive for COVID; Tested positive for COVID; This is a spontaneous report from a contactable Nurse. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular, administered in left arm on 25Jan2021 08:00 (Batch/Lot Number: EL3248) as 1st dose, single, and intramuscular, administered in left arm on 15Feb2021 08:00 (Batch/Lot Number: EL3248) as 2nd dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced tested positive for COVID on 02May2021. Symptoms began a couple days prior with congestion and loss sense of taste/smell. The adverse event resulted in doctor or healthcare professional office/clinic visit. Since the vaccination, the patient has been tested for COVID-19 via Nasal Swab on 02May2021 with positive result. The outcome of the event was recovering/resolving.; Sender's Comments: The reported Tested positive for COVID-19 after immunization is considered vaccination failure of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.